 |
| Saudi Arabia Does not Approve Chinese Vaccine: US or British Booster Must Be Given |
Riyadh (ARK News Latest – International Press Agency – August 25, 2021) Saudi Arabia has not approved the Chinese-made corona vaccine Synovik and Synoform but has said that the citizens of the countries who have vaccinated with Chinese-made vaccine have been approved by Riyadh. The British vaccine Astersenica and the American brands Pfizer’s Johnson & Johnson and Moderna will have to be prescribed.
The World Health Organization (WHO) has called for a halt to the United States’ decision to combine two different brands of vaccines, calling it “dangerous”.
The World Health Organization (WHO) says the experiments in the United States could endanger human lives and do more harm than good. Riyadh-approved British vaccine AustraZeneca and American brands Pfizer’s Johnson & Johnson and Moderna booster will have to be installed.
According to the Arab Broadcasting Corporation, the Saudi Ministry of Health has said that people who have received full doses of SinoVac or SinoPharm vaccine may have their vaccine certificate accepted in the kingdom, who have also received a booster vaccine approved by the kingdom. The ministry had earlier said that two doses of two different vaccines could be taken, but the WHO disagreed.
The ministry said that according to current recommendations, the second dose can be taken at least three weeks after the first dose, while those recovering from Code 19 should receive two doses of the vaccine, at least 10 days after the first infection. The second dose can be given at least 10 days after the infection if the infection occurs after the first dose at least three weeks later.
The Saudi Foreign Ministry added that those wishing to return to the kingdom would have to go through all the steps to ensure that they are free of infection from countries that have barred foreigners from entering Saudi Arabia directly. These included Pakistan, India, UAE, Egypt, Lebanon, Turkey, USA, UK, Germany, France, Italy, Ireland, Portugal, Switzerland, Sweden, Brazil, Argentina, South Africa, Indonesia and Japan.